Trial intelligence / Profile preview

Reduced Primary Schedule for 9-Valent Pneumococcal Conjugate Vaccine in UK Infants

NCT00197769Phase 2Completed

Sponsor
UK Health Security Agency
Start
Sep 2000
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 2 trial of 9-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by UK Health Security Agency. Started Sep 2000; status: completed.

02

Drugs

9-valent pneumococcal conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00197769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00197769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call